Researchers from Singapore's Duke-NUS Medical School, in collaboration with scientists in China, have identified and characterized a new genus of filovirus from a Rousettus bat in China. Their findings were published in the journal Nature Microbiology.
Bat-borne viruses around the world pose a threat to human and animal health. Filoviruses, especially Ebola virus and Marburg virus, are notoriously pathogenic and capable of causing severe and often fatal fever diseases in humans by affecting many organs and damaging blood vessels.
"Studying the genetic diversity and geographic distribution of bat-borne filoviruses is very important for risk assessment and outbreak prevention as this type of infectious disease can affect the general public without warning with devastating consequences," said professor Wang Lin-Fa, director of the Emerging Infectious Diseases Signature Research Prograe at Duke- NUS Medical School, Singapore, and a senior author of the study.
The researchers discovered the new virus while analysing the diversity of filoviruses in Rousettus bats. They named it the Mengla virus because it was discovered in Megla County, Yunnan Province, China. They detected the virus from a bat sample and conducted sequencing and functional characterization studies.
The results showed that the Menga virus represents a new genus named Dianlovirus within the filovirus group. The Mengla virus is genetically distinct, sharing just 32 percent to 54 percent of its genetic sequence with other known filoviruses. It is found in different geographic locations compared to other filoviruses. This new genus, which could include more than one species, sits in between Ebola virus and Marburg virus on the evolutionary tree.
The researchers tested the Mengla virus in cell lines from various animal species and found that, like other filoviruses, it poses a potential risk of interspecies transmission.
The results confirmed that the Mengla virus is evolutionarily closely related to Ebola virus and Marburg virus and shares several important functional similarities with them. For example, the genome organisation of the Mengla virus is consistent with other filoviruses, coding for seven genes. The Mengla virus also uses the same molecular receptor, a protein called NPC1, as Ebola virus and Marburg virus to gain entry into cells and cause infection.
"The early identification of the filovirus from Rousettus bats by professor Wang and researchers in China is one of the many strong research collaborations the Emerging Infectious Diseases (EID) Programme at Duke-NUS engages in," noted professor Patrick Casey of Duke-NUS Medical School. "With globalisation, it is important to identify and assess the risk of potential infectious disease outbreaks and, from it, develop effective controls strategies and treatments."
At present, the virus has only been identified in Rousettus bats in China. Further tests will be conducted to assess the risk of the virus spreading to other species.
Reference: Yang XL, Tan CW, Anderson DE, Jiang RD, Li B, Zhang W, Zhu Y, Lim XF, Zhou P, Liu XL, Guan W, Zhang L, Li SY, Zhang YZ, Wang LF and Shi ZL (2018). Characterization of a filovirus (Mengla virus) from Rousettus bats in China. Nature Microbiology. DOI: 10.1038/s41564-018-0328-y
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
2 Commerce Drive
Cranbury, NJ 08512